Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | Hypofractionated radiotherapy for the management of prostate cancer

Prantik Das • 8 Mar 2019
GU Cancers 2019
Genitourinary Cancer Prostate Cancer

Prantik Das, MBBS, MRCP, FRCR, of the Lincoln County Hospital, Lincoln, UK, speaks at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA. Dr Prantik discusses the use of hypofractionated radiotherapy, delivered by either SABR or high dose rate brachytherapy, for the management of prostate cancer.

More from Prantik Das

1:20
Unmet needs of immunotherapy for bladder cancer
Prantik Das • 18 Feb 2022
1:12
Unmet clinical needs in bladder cancer care in the UK
Prantik Das • 18 Feb 2022
2:12
Real-world study of atezolizumab vs. pembrolizumab for advanced/metastatic UC
Prantik Das • 18 Feb 2022
3:14
The benefits of using patient reported outcomes in prostate cancer
Prantik Das • 8 Mar 2019

Related Videos

10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals